3.4. Apparatus and Chromatographic Conditions

XL Xindan Liu
YZ Ying Zhang
MW Menghua Wu
ZM Zhiguo Ma
HC Hui Cao
request Request a Protocol
ask Ask a question
Favorite

The GC-MS instrument used was an Agilent 7890B GC system coupled to an Agilent 7000C GC/MS Triple Quad mass spectrometer (Agilent, Santa Clara, CA, USA). Initial chromatographic separations of 1 μL of sample were performed on a 15 m × 250 μm i.d. × 0.25 μm film thickness HP-5 (Agilent) capillary column with a He flow rate of 1.0 mL/min and an injection port temperature of 250 °C with a split ratio of 1:10. The oven temperature ramp was 3 min at 50 °C, then 10 °C/min to 90 °C where the temperature was held for 5 min, then ramped at the rate of 10 °C/min to 160 °C where the temperature was maintained for 10 min, then a 20 °C/min ramp to 260 °C where the temperature was held for 3 min. The detector was operated at an ionization energy of 70 eV, and the m/z values were recorded in the range 50–600 amu with a scan rate of 3.6 scan/s and a solvent delay of 3 min. Components were identified using the National Institute of Standards and Technology (NIST) 2.2L Mass Spectra Database containing approximately 189,000 compounds, as well as comparing with literature [27,55,56,57].

HPLC analysis was performed on an UltiMate 3000 liquid chromatography system (Thermo Scientific, Bremen, Germany). Chromatographic separation was performed with an ACE Excel 5 C18 column (4.6 mm × 250 mm, 5 μm; ACE, Scotland, UK), and the column temperature was maintained at 30 °C. The mobile phase was 0.1% formic acid aqueous solution (A) and acetonitrile (B) with a gradient program as follows: 0–20 min, linear gradient from 8–20% B; 20–30 min, isocratic elution at 20% B; 30–50 min, linear gradient from 20–30% B; 50–60 min, linear gradient from 30–8% B. The flow rate was 1 mL/min, and the injection volume was 10 μL. The detection wavelength was set at 283 nm.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A